Home LiteratureArticle Details
PMID: 1398951 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor.

Infection and immunity ·Vol. 60 ·No. 10 ·1992-10-00 ·Pages 4410-3

Furney SK, Skinner PS, Roberts AD, Appelberg R, Orme IM

Abstract

The results of this study show that clinical isolates of Mycobacterium avium fall into two categories in terms of their capacity to grow within murine bone marrow-derived macrophage cultures: those that grow progressively and those that are incapable of growing within such cells. Members of the first category were invariably of the smooth-transparent colonial type, while most of the second were of the smooth-doomed type. In addition, this paper shows that although all isolates induced tumor necrosis factor (TNF) secretion by host cells to some extent, this production was always delayed in isolates that subsequently grew well in the host cells. This observation, coupled with the demonstration that the growth of the latter isolates was inhibited by the exogenous addition of TNF, leads us to hypothesize that the ability of a given isolate to somehow avoid host macrophage TNF production early during the course of the infection is a key factor in the pathogenesis of the disease.

MeSH Terms
Animals Female Lipopolysaccharides/metabolism Macrophages/metabolism,microbiology Mice Mice, Inbred C57BL Mycobacterium avium/growth & development Tumor Necrosis Factor-alpha/biosynthesis
Chemicals
Lipopolysaccharides Tumor Necrosis Factor-alpha lipoarabinomannan
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Furney S K
Department of Microbiology, Colorado State University, Fort Collins 80523.
Skinner P S
Roberts A D
Appelberg R
Orme I M
References (22)
22 references, click to expand
  1. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.
    Cell. 1989 Mar 10;56(5):731-40 PMID: 2647299
  2. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon.
    Infect Immun. 1989 Jan;57(1):239-44 PMID: 2491838
  3. Mycobacterium avium complex infection.
    J Infect Dis. 1988 May;157(5):863-7 PMID: 3283260
  4. Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.
    Ann Intern Med. 1983 Dec;99(6):782-5 PMID: 6359997
  5. Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.
    J Immunol. 1989 Nov 1;143(9):2996-3000 PMID: 2553816
  6. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    J Immunol. 1988 May 1;140(9):3006-13 PMID: 2834450
  7. Mycobacteria and AIDS mortality.
    Am Rev Respir Dis. 1989 Jan;139(1):1-3 PMID: 2912328
  8. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Eur J Immunol. 1988 Oct;18(10):1587-92 PMID: 3142779
  9. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.
    J Clin Microbiol. 1986 Nov;24(5):812-21 PMID: 3771767
  10. Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation.
    J Biol Chem. 1974 Dec 10;249(23):7679-84 PMID: 4612040
  11. Differential release of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex.
    J Infect Dis. 1992 Apr;165(4):702-9 PMID: 1552199
  12. Natural history of disseminated Mycobacterium avium complex infection in AIDS.
    J Infect Dis. 1991 Nov;164(5):994-8 PMID: 1682396
  13. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    J Leukoc Biol. 1991 Apr;49(4):380-7 PMID: 1900522
  14. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes.
    J Immunol. 1991 May 1;146(9):3165-70 PMID: 1901893
  15. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.
    N Engl J Med. 1991 May 9;324(19):1332-8 PMID: 2017230
  16. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
    J Infect Dis. 1991 Jun;163(6):1326-35 PMID: 2037799
  17. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome.
    Infect Immun. 1990 Aug;58(8):2564-8 PMID: 2370109
  18. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor.
    Infect Immun. 1992 Mar;60(3):1249-53 PMID: 1541542
  19. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
    Clin Exp Immunol. 1991 Mar;83(3):466-71 PMID: 1900745
  20. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins.
    J Immunol. 1990 Jun 15;144(12):4817-24 PMID: 1972169
  21. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.
    Immunology. 1990 Sep;71(1):139-41 PMID: 2120128
  22. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).
    Am Rev Respir Dis. 1989 Jan;139(1):4-7 PMID: 2912355
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1992-10-00
Pages
4410-3
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC257480
Subset
IM
Grants
NIAID NIH HHS · AI30189 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com